In children with DS, there was a fall in CD11b after SsnB and Pam3Csk4 treatment (p = 0.04); in both cohorts, there was no decrease after treatment with SsnB and both proinflammatory stimulants (Figure 3(d)). The gene discussed is ITGAM; the disease is Dravet syndrome.